Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tracon Pharma (TCON)

Tracon Pharma (TCON)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 82,966
  • Shares Outstanding, K 19,430
  • Annual Sales, $ 0 K
  • Annual Income, $ -16,780 K
  • 60-Month Beta 1.88
  • Price/Sales 170.79
  • Price/Cash Flow N/A
  • Price/Book 6.43
Trade TCON with:

Options Overview Details

View History
  • Implied Volatility 112.25%
  • Historical Volatility 45.64%
  • IV Percentile 13%
  • IV Rank 8.08%
  • IV High 406.10% on 01/19/21
  • IV Low 86.43% on 09/22/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 19
  • Volume Avg (30-Day) 185
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 134
  • Open Int (30-Day) 156

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.32
  • Number of Estimates 2
  • High Estimate -0.32
  • Low Estimate -0.32
  • Prior Year -0.38
  • Growth Rate Est. (year over year) +15.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.66 +16.54%
on 09/14/21
4.45 -4.04%
on 09/24/21
+0.33 (+8.38%)
since 08/24/21
3-Month
3.21 +33.02%
on 08/17/21
7.23 -40.94%
on 06/25/21
-2.55 (-37.39%)
since 06/24/21
52-Week
3.21 +33.02%
on 08/17/21
12.20 -65.00%
on 01/04/21
-0.59 (-12.14%)
since 09/24/20

Most Recent Stories

More News
TRACON Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit

TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient,...

TCON : 4.27 (-1.61%)
TRACON Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient,...

TCON : 4.27 (-1.61%)
Tracon: Q2 Earnings Snapshot

SAN DIEGO (AP) _ Tracon Pharmaceuticals Inc. (TCON) on Wednesday reported a loss of $8.9 million in its second quarter.

TCON : 4.27 (-1.61%)
TRACON Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent...

TCON : 4.27 (-1.61%)
TRACON Pharmaceuticals Announces Results of Second Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal Trial

TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient,...

TCON : 4.27 (-1.61%)
TRACON Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference

TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient,...

TCON : 4.27 (-1.61%)
TRACON to Report Second Quarter 2021 Financial Results and Company Highlights on August 11, 2021

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent...

TCON : 4.27 (-1.61%)
TRACON Pharmaceuticals Increases Previously Announced Bought Deal Offering of Common Stock to $15.0 Million

TRACON Pharmaceuticals (NASDAQ: TCON) ("TRACON" or the "Company"), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics, today...

TCON : 4.27 (-1.61%)
TRACON Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock

TRACON Pharmaceuticals (NASDAQ: TCON) ("TRACON" or the "Company"), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics, today...

TCON : 4.27 (-1.61%)
TRACON Pharmaceuticals Announces Appointment of Brenda Marczi, PharmD, as Senior Vice President, Regulatory Affairs, and Granting of Inducement Award

TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient,...

TCON : 4.27 (-1.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

TRACON Pharmaceuticals, Inc. is a biopharmaceutical company. The company's product candidate includes TRC105, TRC205 and TRC102 which are in different clinical stage for cancer, age-related macular degeneration and fibrotic diseases. TRACON Pharmaceuticals, Inc. is headquartered in San Diego, California....

See More

Key Turning Points

3rd Resistance Point 4.78
2nd Resistance Point 4.62
1st Resistance Point 4.44
Last Price 4.27
1st Support Level 4.10
2nd Support Level 3.94
3rd Support Level 3.76

See More

52-Week High 12.20
Fibonacci 61.8% 8.77
Fibonacci 50% 7.70
Fibonacci 38.2% 6.64
Last Price 4.27
52-Week Low 3.21

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar